IDEAYA Biosciences (IDYA) Competitors $30.51 +1.25 (+4.27%) Closing price 04:00 PM EasternExtended Trading$30.42 -0.09 (-0.29%) As of 06:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IDYA vs. RVMD, ABVX, RNA, CYTK, MRUS, RYTM, CRSP, GRFS, NUVL, and AXSMShould you be buying IDEAYA Biosciences stock or one of its competitors? The main competitors of IDEAYA Biosciences include Revolution Medicines (RVMD), Abivax (ABVX), Avidity Biosciences (RNA), Cytokinetics (CYTK), Merus (MRUS), Rhythm Pharmaceuticals (RYTM), CRISPR Therapeutics (CRSP), Grifols (GRFS), Nuvalent (NUVL), and Axsome Therapeutics (AXSM). These companies are all part of the "pharmaceutical products" industry. IDEAYA Biosciences vs. Its Competitors Revolution Medicines Abivax Avidity Biosciences Cytokinetics Merus Rhythm Pharmaceuticals CRISPR Therapeutics Grifols Nuvalent Axsome Therapeutics Revolution Medicines (NASDAQ:RVMD) and IDEAYA Biosciences (NASDAQ:IDYA) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, institutional ownership, earnings, analyst recommendations and profitability. Do analysts prefer RVMD or IDYA? Revolution Medicines presently has a consensus price target of $76.67, suggesting a potential upside of 41.95%. IDEAYA Biosciences has a consensus price target of $43.36, suggesting a potential upside of 42.11%. Given IDEAYA Biosciences' higher possible upside, analysts clearly believe IDEAYA Biosciences is more favorable than Revolution Medicines.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Revolution Medicines 1 Sell rating(s) 0 Hold rating(s) 13 Buy rating(s) 1 Strong Buy rating(s) 2.93IDEAYA Biosciences 1 Sell rating(s) 3 Hold rating(s) 14 Buy rating(s) 0 Strong Buy rating(s) 2.72 Which has preferable valuation & earnings, RVMD or IDYA? IDEAYA Biosciences has lower revenue, but higher earnings than Revolution Medicines. Revolution Medicines is trading at a lower price-to-earnings ratio than IDEAYA Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRevolution Medicines$11.58M871.86-$600.09M-$4.50-12.00IDEAYA Biosciences$7M381.99-$274.48M-$3.79-8.05 Do institutionals and insiders hold more shares of RVMD or IDYA? 94.3% of Revolution Medicines shares are held by institutional investors. Comparatively, 98.3% of IDEAYA Biosciences shares are held by institutional investors. 8.2% of Revolution Medicines shares are held by insiders. Comparatively, 2.5% of IDEAYA Biosciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Is RVMD or IDYA more profitable? IDEAYA Biosciences' return on equity of -31.42% beat Revolution Medicines' return on equity.Company Net Margins Return on Equity Return on Assets Revolution MedicinesN/A -41.78% -35.63% IDEAYA Biosciences N/A -31.42%-29.45% Which has more volatility & risk, RVMD or IDYA? Revolution Medicines has a beta of 1.27, suggesting that its stock price is 27% more volatile than the S&P 500. Comparatively, IDEAYA Biosciences has a beta of 0.14, suggesting that its stock price is 86% less volatile than the S&P 500. Does the media favor RVMD or IDYA? In the previous week, Revolution Medicines had 7 more articles in the media than IDEAYA Biosciences. MarketBeat recorded 15 mentions for Revolution Medicines and 8 mentions for IDEAYA Biosciences. Revolution Medicines' average media sentiment score of 0.78 beat IDEAYA Biosciences' score of 0.65 indicating that Revolution Medicines is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Revolution Medicines 7 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive IDEAYA Biosciences 3 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryRevolution Medicines and IDEAYA Biosciences tied by winning 8 of the 16 factors compared between the two stocks. Get IDEAYA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IDYA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IDYA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IDYA vs. The Competition Export to ExcelMetricIDEAYA BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.67B$3.48B$6.17B$10.68BDividend YieldN/A2.27%5.70%4.84%P/E Ratio-8.0523.3929.4727.36Price / Sales381.99485.50589.24132.03Price / CashN/A45.2825.8230.35Price / Book2.4910.6112.526.69Net Income-$274.48M-$52.56M$3.32B$276.59M7 Day Performance13.97%4.94%2.43%0.97%1 Month Performance18.53%16.10%8.78%3.95%1 Year Performance-0.10%14.51%62.11%36.40% IDEAYA Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IDYAIDEAYA Biosciences4.3936 of 5 stars$30.51+4.3%$43.36+42.1%-4.2%$2.56B$7M0.0080News CoverageRVMDRevolution Medicines4.4592 of 5 stars$48.75+1.1%$74.64+53.1%+7.3%$9.02B$11.58M-10.83250Analyst ForecastABVXAbivax3.5934 of 5 stars$95.63+2.0%$114.25+19.5%+787.4%$7.30BN/A0.0061Short Interest ↓RNAAvidity Biosciences2.6117 of 5 stars$48.96-1.6%$68.32+39.5%-5.1%$7.26B$10.90M-13.75190Insider TradeCYTKCytokinetics3.889 of 5 stars$59.59-0.7%$76.64+28.6%+6.3%$7.18B$18.47M-11.68250MRUSMerus1.4233 of 5 stars$94.85+0.5%$93.12-1.8%+80.1%$7.14B$36.13M-17.2537Short Interest ↓RYTMRhythm Pharmaceuticals2.8957 of 5 stars$100.770.0%$106.64+5.8%+116.9%$6.70B$130.13M-33.48140Positive NewsAnalyst ForecastInsider TradeCRSPCRISPR Therapeutics1.9385 of 5 stars$68.29-6.5%$71.71+5.0%+41.4%$6.65B$37.31M-12.58460Analyst ForecastInsider TradeAnalyst RevisionGap UpGRFSGrifols3.9382 of 5 stars$9.45+1.4%$10.30+9.0%+11.6%$6.41B$7.81B8.0823,822Positive NewsNUVLNuvalent2.5573 of 5 stars$89.75+1.9%$118.89+32.5%-10.8%$6.35BN/A-18.3240Insider TradeAnalyst RevisionAXSMAxsome Therapeutics4.7758 of 5 stars$121.15-0.5%$177.93+46.9%+37.1%$6.07B$385.69M-23.90380Positive NewsAnalyst Forecast Related Companies and Tools Related Companies Revolution Medicines Alternatives Abivax Alternatives Avidity Biosciences Alternatives Cytokinetics Alternatives Merus Alternatives Rhythm Pharmaceuticals Alternatives CRISPR Therapeutics Alternatives Grifols Alternatives Nuvalent Alternatives Axsome Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IDYA) was last updated on 10/20/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | SponsoredTrump’s “Smart Dollar” just went mainstream"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredGold surges past $4,200 … but this has beat gold by 1,000xGold has surged past $4,200 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredTrump Issues Surprise Emergency OrderIs This Stock the 'Next Nvidia'? Billionaire Warren Buffett has been loading up on millions of shares of th...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IDEAYA Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IDEAYA Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
